160 related articles for article (PubMed ID: 35197517)
1. Mitochondrial dysfunction associated with TANGO2 deficiency.
Heiman P; Mohsen AW; Karunanidhi A; St Croix C; Watkins S; Koppes E; Haas R; Vockley J; Ghaloul-Gonzalez L
Sci Rep; 2022 Feb; 12(1):3045. PubMed ID: 35197517
[TBL] [Abstract][Full Text] [Related]
2. TANGO2 deficiency as a cause of neurodevelopmental delay with indirect effects on mitochondrial energy metabolism.
Jennions E; Hedberg-Oldfors C; Berglund AK; Kollberg G; Törnhage CJ; Eklund EA; Oldfors A; Verloo P; Vanlander AV; De Meirleir L; Seneca S; Sterky FH; Darin N
J Inherit Metab Dis; 2019 Sep; 42(5):898-908. PubMed ID: 31276219
[TBL] [Abstract][Full Text] [Related]
3. Clinical and biological characterization of 20 patients with TANGO2 deficiency indicates novel triggers of metabolic crises and no primary energetic defect.
Bérat CM; Montealegre S; Wiedemann A; Nuzum MLC; Blondel A; Debruge H; Cano A; Chabrol B; Hoebeke C; Polak M; Stoupa A; Feillet F; Torre S; Boddaert N; Bruel H; Barth M; Damaj L; Abi-Wardé MT; Afenjar A; Benoist JF; Madrange M; Caccavelli L; Renard P; Hubas A; Nusbaum P; Pontoizeau C; Gobin S; van Endert P; Ottolenghi C; Maltret A; de Lonlay P
J Inherit Metab Dis; 2021 Mar; 44(2):415-425. PubMed ID: 32929747
[TBL] [Abstract][Full Text] [Related]
4. The phenotype associated with variants in TANGO2 may be explained by a dual role of the protein in ER-to-Golgi transport and at the mitochondria.
Milev MP; Saint-Dic D; Zardoui K; Klopstock T; Law C; Distelmaier F; Sacher M
J Inherit Metab Dis; 2021 Mar; 44(2):426-437. PubMed ID: 32909282
[TBL] [Abstract][Full Text] [Related]
5. Clinical presentation and proteomic signature of patients with TANGO2 mutations.
Mingirulli N; Pyle A; Hathazi D; Alston CL; Kohlschmidt N; O'Grady G; Waddell L; Evesson F; Cooper SBT; Turner C; Duff J; Topf A; Yubero D; Jou C; Nascimento A; Ortez C; García-Cazorla A; Gross C; O'Callaghan M; Santra S; Preece MA; Champion M; Korenev S; Chronopoulou E; Anirban M; Pierre G; McArthur D; Thompson K; Navas P; Ribes A; Tort F; Schlüter A; Pujol A; Montero R; Sarquella G; Lochmüller H; Jiménez-Mallebrera C; Taylor RW; Artuch R; Kirschner J; Grünert SC; Roos A; Horvath R
J Inherit Metab Dis; 2020 Mar; 43(2):297-308. PubMed ID: 31339582
[TBL] [Abstract][Full Text] [Related]
6. Bi-allelic Truncating Mutations in TANGO2 Cause Infancy-Onset Recurrent Metabolic Crises with Encephalocardiomyopathy.
Kremer LS; Distelmaier F; Alhaddad B; Hempel M; Iuso A; Küpper C; Mühlhausen C; Kovacs-Nagy R; Satanovskij R; Graf E; Berutti R; Eckstein G; Durbin R; Sauer S; Hoffmann GF; Strom TM; Santer R; Meitinger T; Klopstock T; Prokisch H; Haack TB
Am J Hum Genet; 2016 Feb; 98(2):358-62. PubMed ID: 26805782
[TBL] [Abstract][Full Text] [Related]
7. Clinical phenotype associated with TANGO2 gene mutation.
Hoebeke C; Cano A; De Lonlay P; Chabrol B
Arch Pediatr; 2021 Jan; 28(1):80-86. PubMed ID: 33342685
[TBL] [Abstract][Full Text] [Related]
8. Defects in lipid homeostasis reflect the function of TANGO2 in phospholipid and neutral lipid metabolism.
Lujan AL; Foresti O; Sugden C; Brouwers N; Farre AM; Vignoli A; Azamian M; Turner A; Wojnacki J; Malhotra V
Elife; 2023 Mar; 12():. PubMed ID: 36961129
[TBL] [Abstract][Full Text] [Related]
9. TANGO2: expanding the clinical phenotype and spectrum of pathogenic variants.
Dines JN; Golden-Grant K; LaCroix A; Muir AM; Cintrón DL; McWalter K; Cho MT; Sun A; Merritt JL; Thies J; Niyazov D; Burton B; Kim K; Fleming L; Westman R; Karachunski P; Dalton J; Basinger A; Ficicioglu C; Helbig I; Pendziwiat M; Muhle H; Helbig KL; Caliebe A; Santer R; Becker K; Suchy S; Douglas G; Millan F; Begtrup A; Monaghan KG; Mefford HC
Genet Med; 2019 Mar; 21(3):601-607. PubMed ID: 30245509
[TBL] [Abstract][Full Text] [Related]
10. TANGO2 Deficiency Disorder: Two Cases of Developmental Delay Preceding Metabolic Crisis.
Dias JV; Carvalho AA; Freixo JP; Antunes D; Martins AA; Painho T; Jacinto S
Pediatr Neurol; 2023 Oct; 147():52-55. PubMed ID: 37562170
[TBL] [Abstract][Full Text] [Related]
11. Homozygous TANGO2 Single Nucleotide Variants Presenting with Additional Manifestations Resembling Alternating Hemiplegia of Childhood-Expanding the Phenotype of a Recently Reported Condition.
Sen K; Hicks MA; Huq AHM; Agarwal R
Neuropediatrics; 2019 Apr; 50(2):122-125. PubMed ID: 30650451
[TBL] [Abstract][Full Text] [Related]
12. Limb-girdle myopathy and mild intellectual disability: The expanding spectrum of TANGO2-related disease.
Restrepo-Vera JL; Muñoz-Cabello P; Pérez-Rodon J; Rovira-Moreno E; Codina-Solà M; Llauradó A; Salvadó M; Sánchez-Tejerina D; Sotoca J; Martínez-Sáez E; García-Arumí E; Juntas-Morales R
Neuromuscul Disord; 2023 Jun; 33(6):463-467. PubMed ID: 37119590
[TBL] [Abstract][Full Text] [Related]
13. Clinical phenotype associated with variants in TANGO2: A case study.
Alghamdi F; Alharbi A; Mohamed F; Alghamdi A; Bashir S
Arch Pediatr; 2023 Aug; 30(6):438-440. PubMed ID: 37394363
[TBL] [Abstract][Full Text] [Related]
14. Management of acute metabolic crisis in TANGO2 deficiency: a case report.
Yılmaz-Gümüş E; Elcioglu NH; Genç E; Arıcı Ş; Öztürk G; Yapıcı Ö; Akalın F; Öztürk-Hişmi B
J Pediatr Endocrinol Metab; 2023 Oct; 36(10):983-987. PubMed ID: 37381587
[TBL] [Abstract][Full Text] [Related]
15. Variable clinical severity in TANGO2 deficiency: Case series and literature review.
Schymick J; Leahy P; Cowan T; Ruzhnikov MRZ; Gates R; Fernandez L; Pramanik G; ; Yarlagadda V; Wheeler M; Bernstein JA; Enns GM; Lee C
Am J Med Genet A; 2022 Feb; 188(2):473-487. PubMed ID: 34668327
[TBL] [Abstract][Full Text] [Related]
16. Intrinsic and extrinsic regulation of rhabdomyolysis susceptibility by Tango2.
Kim ES; Casey JG; Tao BS; Mansur A; Mathiyalagan N; Wallace ED; Ehrmann BM; Gupta VA
Dis Model Mech; 2023 Sep; 16(9):. PubMed ID: 37577943
[TBL] [Abstract][Full Text] [Related]
17. Recurrent Muscle Weakness with Rhabdomyolysis, Metabolic Crises, and Cardiac Arrhythmia Due to Bi-allelic TANGO2 Mutations.
Lalani SR; Liu P; Rosenfeld JA; Watkin LB; Chiang T; Leduc MS; Zhu W; Ding Y; Pan S; Vetrini F; Miyake CY; Shinawi M; Gambin T; Eldomery MK; Akdemir ZH; Emrick L; Wilnai Y; Schelley S; Koenig MK; Memon N; Farach LS; Coe BP; Azamian M; Hernandez P; Zapata G; Jhangiani SN; Muzny DM; Lotze T; Clark G; Wilfong A; Northrup H; Adesina A; Bacino CA; Scaglia F; Bonnen PE; Crosson J; Duis J; Maegawa GH; Coman D; Inwood A; McGill J; Boerwinkle E; Graham B; Beaudet A; Eng CM; Hanchard NA; Xia F; Orange JS; Gibbs RA; Lupski JR; Yang Y
Am J Hum Genet; 2016 Feb; 98(2):347-57. PubMed ID: 26805781
[TBL] [Abstract][Full Text] [Related]
18. ETHE1 and MOCS1 deficiencies: Disruption of mitochondrial bioenergetics, dynamics, redox homeostasis and endoplasmic reticulum-mitochondria crosstalk in patient fibroblasts.
Grings M; Seminotti B; Karunanidhi A; Ghaloul-Gonzalez L; Mohsen AW; Wipf P; Palmfeldt J; Vockley J; Leipnitz G
Sci Rep; 2019 Sep; 9(1):12651. PubMed ID: 31477743
[TBL] [Abstract][Full Text] [Related]
19. Transport and Golgi organization 2 deficiency with a prominent elevation of C14:1 during a metabolic crisis: A case report.
Yokoi K; Nakajima Y; Takahashi Y; Hamajima T; Tajima G; Saito K; Miyai S; Inagaki H; Yoshikawa T; Kurahashi H; Ito T
JIMD Rep; 2023 Jan; 64(1):3-9. PubMed ID: 36636595
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
